Zhitong Finance App News, Baiyunshan (00874) announced that recently, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (hereinafter referred to as “Tianxin Pharmaceutical”), the holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration. Amikacin sulfate injection (2ml: 0.2g) (200,000 units) has passed the consistent evaluation of generic drug quality and efficacy.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.